CCR3 blockade as a new therapy for asthma

References

• BAGGIOLINI M, DEWALD B, MOSER B: Human chemokines: an update. Ann. Rev. Immunol. (1997) 15:675–705.
   PubMed Web of Science ®Google Scholar
• BAGGIOLINI M: Chemokines and leukocyte traffic. Nature (1998) 392:565–568.
   PubMed Web of Science ®Google Scholar
• LOCATI M, MURPHY PM: Chemokines and chemokine receptors: biology and clinical relevance in inflamma-tion and AIDS. Ann. Rev. Med. (1999) 50:425–440.
   PubMed Web of Science ®Google Scholar
• WELLS TNC, PROUDFOOT AEI, POWER CA: Chemokine receptors and their role in leukocyte activation. Immunol. Lett. (1999) 65:35–40.
   PubMed Web of Science ®Google Scholar
• ZLOTNIK A, MORALES J, HEDRICK JA: Recent advances in chemokines and chemokine receptors. Grit. Rev. Immunol. (1999) 19:1–47.
   PubMed Web of Science ®Google Scholar
• BOUSQUET J, CHANEZ P, CAMPBELL AM, VIGNOLA AM, GODARD P: Cellular inflammation in asthma. Clin. Exp. Allergy (1995) 25 (Suppl. 2):39–42.
   Google Scholar
• BUSSE WW: Inflammation in asthma: the cornerstone of the disease and target of therapy. J. Allergy Clin. Immunol. (1998) 102:S17–22.
   PubMed Web of Science ®Google Scholar
• O'BYRNE PM: Airway inflammation and asthma. Aliment. Pharmacol. Ther. (1996) 10:18–24.
   Google Scholar
• GRIFFITHS-JOHNSON DA, COLLINS PD, ROSSI AG, JOSE PJ, WILLIAMS TJ: The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem. Biophys. Res. Commun. (1993) 197:1167–1172.
   PubMed Web of Science ®Google Scholar
• JOSE PJ, GRIFFITHS-JOHNSON DA, COLLINS PD et al.: Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. (1994) 179:881–7.
   PubMed Web of Science ®Google Scholar
• JOSE PJ, ADCOCK IM, GRIFFITHS-JOHNSON DA et al: Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem. Biophys. Res. Commun. (1994) 205:788–94.
   PubMed Web of Science ®Google Scholar
• WILLIAMS CM, NEWTON DJ, WILSON SA eta].: Conserved structure and tissue expression of rat eotaxin. Immunogenetics (1998) 47:178–80.
   Google Scholar
• CHEN J, AKYUREK LM, FELLSTROM B, HAYRY P, PAUL LC: Eotaxin and capping protein in experimental vasculo-pathy. Am. J. Pathol. (1998) 153:81–90.
   PubMed Web of Science ®Google Scholar
• ISHI Y, SHIRATO M, NOMURA A et al: Cloning of rat eotaxin: ozone inhalation increases mRNA and protein expression in lungs of brown Norway rats. Am. J. Physiol (1998) 274:L171–176.
   Google Scholar
• PONATH PD, QIN SX, RINGLER DJ et al.: Cloning of the human eosinophil chemoattractant, eotaxin - expres-sion, receptor binding and functional properties suggest a mechanism for the selective recruitment of eosinophils. j Clin. Invest. (1996) 97:604–612.
   PubMed Web of Science ®Google Scholar
• ROTHENBERG ME, LUSTER AD, LEDER P: Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA (1995) 92:8960–8964.
   PubMed Web of Science ®Google Scholar
• LAMKHIOUED B, RENZI PM, ABIYOUNES S et al: Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. Immunol (1997) 159:4593–4601.
   Web of Science ®Google Scholar
• LILLY CM, NAKAMURA H, KESSELMAN H et al.: Expres-sion of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorti-coids. j Clin. Invest. (1997) 99:1767–1773.
   PubMed Web of Science ®Google Scholar
• MOCHIZUKI M, BARTELS J, MALLET Al, CHRISTOPHERS E, SCHRODER JM: 11–4 induces eotaxin - a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. 1 Immunol. (1998) 160:60–68.
   Google Scholar
• GARCIAZEPEDA EA, ROTHENBERG ME, OWNBEY RT etal: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med. (1996) 2:449–456.
   PubMed Web of Science ®Google Scholar
• NAKAJIMA T, YAMADA H, IIKURA M et al: Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett. (1998) 434:226–230.
   PubMed Web of Science ®Google Scholar
• ROTHENBERG ME, LUSTER AD, LILLY CM, DRAZEN JM, LEDER P: Constitutive and allergen-induced expres-sion of eotaxin mRNA in the guinea pig lung. J. Exp. Med. (1995) 181:1211–1216.
   PubMed Web of Science ®Google Scholar
• GANZALO JA, JIA GQ, AGUIRRE V et al.: Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity (1996) 4:1–14.
   PubMed Web of Science ®Google Scholar
• HUMBLES AA, CONROY DM, MARLEAU S et al.: Kinetics of eotaxin generation and its relationship to eosino-phil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. (1997) 186:601–612.
   PubMed Web of Science ®Google Scholar
• LI D, WANG D, GRIFFITHS-JOHNSON DA et al: Eotaxin protein and gene expression in guinea-pig lungs: constitutive expression and upregulation after allergen challenge. Eur. Respir. J. (1997) 10:1946–1954.
   PubMed Web of Science ®Google Scholar
• POST TW, BOZIC CR, ROTHENBERG ME et al.: Molecular characterization of two murine eosinophil beta chemokine receptors. J. Immunol. (1995) 155:5299–5305.
   PubMed Web of Science ®Google Scholar
• GAO JL, MURPHY PM: Cloning and differential tissue-specific expression of three mouse beta chemokine receptor-like genes, including the gene for a functional macrophage inflammatory protein-1 alpha receptor. J. Biol. Chem. (1995) 270:17494–17501.
   PubMed Web of Science ®Google Scholar
• GAO JL, SEN Al, KITAURA M et al: Identification of a mouse eosinophil receptor for the CC chemokine eotaxin. Biochem. Biophys. Res. Commun. (1996) 223:679–684.
   PubMed Web of Science ®Google Scholar
• COMBADIERE C, AHUJA S, MURPHY PM: Cloning and functional expression of a human eosinophil CC chemokine receptor. J. Biol. Chem. (1995) 270:16491–16494.
   PubMed Web of Science ®Google Scholar
• DAUGHERTY BL, SICILIANO SJ, DEMARTINO JA et al:Cloning, expression and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. (1996) 183:2349–2354.
   PubMed Web of Science ®Google Scholar
• PONATH PD, QIN SX, POST TW et al: Molecular cloningand characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. (1996) 183:2437–2448.
   PubMed Web of Science ®Google Scholar
• HEATH H, QIN SX, RAO P et al: Chemokine RECEPTOR USAGE BY HUMAN EOSINOPHILS - the importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. (1997) 99:178–184.
   PubMed Web of Science ®Google Scholar
• STELLATO C, COLLINS P, PONATH PD et al.: Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. 1 Clin. Invest. (1997) 99:926–936.
   Google Scholar
• WHITE JR, IMBURGIA C, DUL E et al: Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. 1 Leukoc. Biol. (1997) 62:667–675.
   PubMed Web of Science ®Google Scholar
• GARCIAZEPEDA EA, COMBADIERE C, ROTHENBERG ME et al: Human monocyte chemoattractant protein (Mcp)-4 is a novel CC chemokine with activities on monocytes, eosinophils and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3.j Immunol. (1996) 157:5613–5626.
   PubMed Web of Science ®Google Scholar
• ELSNER J, HOCHSTETTER R, KIMMIG D, KAPP A: Human eotaxin represents a potent activator of the respira-tory burst of human eosinophils. Eur. J. Immunol (1996) 26:1919–1925.
   PubMed Web of Science ®Google Scholar
• BOEHME SA, SULLIVAN SK, CROWE PD et al.: Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J. Immunol (1999) 163:1611–1618.
   PubMed Web of Science ®Google Scholar
• ZIMMERMANN N, CONKRIGHT JJ, ROTHENBERG ME: CCchemokine receptor-3 undergoes prolonged ligand-induced internalization. J. Biol. Chem. (1999) 274: 12611–12618.
   PubMed Web of Science ®Google Scholar
• UGUCCIONI M, MACKAY CR, OCHENSBERGER B et al.:High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4 and other chemokines. J. Clin. Invest. (1997) 100:1137–1143.
   Google Scholar
• PARK IW, KOZIEL H, HATCH W et al.: CD4 receptor-dependent entry of human immunodeficiency virus type-1 env- pseudotypes into CCR5-, CCR3- and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor. Am. J. Respir. Cell Mol. Biol. (1999) 20:864–871.
   PubMed Web of Science ®Google Scholar
• SALLUSTO F, MACKAY CR, LANZAVECCHIA A: Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science (1997) 277: 2005-2007.
   Google Scholar
• BONECCHI R, BIANCHI G, BORDIGNON PP et al.: Differ-ential expression of chemokine receptors and chemotactic responsiveness of Type 1 T helper cells (This) and Th2s. J. Exp. Med. (1998) 187:129–134.
   PubMed Web of Science ®Google Scholar
• D'AMBROSIO D, IELLEM A, BONECCHI R et al.: Selectiveup-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human Type 2 Th cells. J. Immunol. (1998) 161:5111–5115.
   Google Scholar
• JINQUAN T, QUAN S, FEILI G, LARSEN CG, THESTRUP-PEDERSEN K: Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with I1-4. j Immunol. (1999) 162:4285–4292.
   PubMed Web of Science ®Google Scholar
• SALLUSTO F, LENIG D, MACKAY CR, LANZAVECCHIA A:Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. (1998) 187:875–883.
   PubMed Web of Science ®Google Scholar
• MIYAMASU M, NAKAJIMA T, MISAKI Y et al: Dermalfibroblasts represent a potent major source of human eotaxin: In vitro production and cytokine-mediated regulation [In process citation]. Cytokine (1999) 11:751–758.
   PubMed Web of Science ®Google Scholar
• MOCHIZUKI M, SCHRODER J, CHRISTOPHERS E, YAMAMOTO S: 11-4 induces eotaxin in human dermal fibroblasts [in process citation]. Int. Arch. Allergy Immunol. (1999) 120:19–23.
   PubMed Web of Science ®Google Scholar
• MIYAMASU M, YAMAGUCHI M, NAKAJIMA T et al: Thl-derived cytokine IFN-gamma is a potent inhibitor of eotaxin synthesis in vitro. Int. Immunol. (1999) 11:1001–1004.
   PubMed Web of Science ®Google Scholar
• TERAN LM, MOCHIZUKI M, BARTELS J et al.: Thl- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am. J. Resp. Cell Mol. Biol. (1999) 20:777–786.
   PubMed Web of Science ®Google Scholar
• LI L, XIA YY, NGUYEN A et al.: Effects of Th2 cytokines on chemokine expression in the lung: 11-13 potently induces eotaxin expression by airway epithelial cells. Immunol (1999) 162:2477–2487.
   Web of Science ®Google Scholar
• GARCIAZEPEDA EA, ROTHENBERG ME, WEREMOWICZ Set al.: Genomic organization, complete sequence and chromosomal location of the gene for human eotaxin (Scya 1 1), an eosinophil-specific Cc chemokine. Genomics (1997) 41:471–476.
   Google Scholar
• DEVOUASSOUX G, METCALFE DD, PRUSSIN C: Eotaxinpotentiates antigen-dependent basophil 11-4 produc-tion. J. Immunol (1999) 163:2877–2882.
   PubMed Web of Science ®Google Scholar
• FORSSMANN U, UGUCCIONI M, LOETSCHER P et al.: Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3 and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. (1997) 185:2171–2176.
   PubMed Web of Science ®Google Scholar
• ELSNER J, PETERING H, KLUTHE C et al.: Eotaxin-2activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils. Eur. J. Immunol (1998) 28:2152–2158.
   PubMed Web of Science ®Google Scholar
• SHINKAI A, YOSHISUE H, KOIKE M et al.: A novel humanCC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J. Immunol. (1999) 163:1602–1610.
   PubMed Web of Science ®Google Scholar
• COLLINS PD, MARLEAU S, GRIFFITHS-JOHNSON DA, JOSE PJ, WILLIAMS TJ: Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. (1995) 182:1169–1174.
   PubMed Web of Science ®Google Scholar
• PALFRAMAN RT, COLLINS PD, WILLIAMS TJ, RANKIN SM: Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood (1998) 91:2240–2248.
   PubMed Web of Science ®Google Scholar
• TAHA RA, MINSHALL EM, MIOTTO D et al.: Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J. Allergy Clin. Immunol. (1999) 103:476–483.
   PubMed Web of Science ®Google Scholar
• YING S, ROBINSON DS, MENG Q etal: Enhanced expres-sion of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsive-ness and predominant co- localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur. j Immunol. (1997) 27:3507–3516.
   Google Scholar
• GHAFFAR 0, HAMID Q, RENZI PM et al.: Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. Am. J. Respir. Grit. Care Med. (1999) 159:1933–1942.
   Google Scholar
• LILLY CM, WOODRUFF PG, CAMARGO CA JR et al.: Elevated plasma eotaxin levels in patients with acute asthma. J. Allergy Clin. Immunol (1999) 104:786–790.
   Google Scholar
• RUTH JH, LUKACS NW, WARMINGTON KS et al.: Expres-sion and participation of eotaxin during mycobacte-rial (type 1) and schistosomal (type 2) antigen-elicited granuloma formation. J. Immunol. (1998) 161:4276–82.
   PubMed Web of Science ®Google Scholar
• CAMPBELL EM, KUNKEL SL, STRIETER RM, LUKACS NW: Temporal role of chemokines in a murine model of cockroach allergen- induced airway hyperreactivity and eosinophilia. j Immunol. (1998) 161:7047–7053.
   PubMed Web of Science ®Google Scholar
• GONZALO JA, LLOYD CM, WEN DY et al.: The coordi-nated action of cc chemokines in the lung orchestrates allergic inflammation and airway hyperresponsive-ness. J. Exp. Med. (1998) 188:157–167.
   PubMed Web of Science ®Google Scholar
• MATTHEWS AN, FRIEND DS, ZIMMERRMANN N et al.: Eotaxin is required for the baseline level of tissue eosinophils. Proc. Natl. Acad. Sci. USA (1998) 95:6273–6278.
   PubMed Web of Science ®Google Scholar
• MISHRA A, HOGAN SP, LEE JJ, FOSTER PS, ROTHENBERG ME: Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J. Clin. Invest. (1999) 103:1719–1727.
   PubMed Web of Science ®Google Scholar
• ROTHENBERG ME, MACLEAN JA, PEARLMAN E, LUSTER AD, LEDER P: Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. (1997) 185:785–790.
   PubMed Web of Science ®Google Scholar
• YANG Y, LOY J, RYSECK RP, CARRASCO D, BRAVO R: Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood (1998) 92:3912–3923.
   PubMed Web of Science ®Google Scholar
• YING S, ROBINSON DS, MENG Q et al.: C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia and relationship to basophils and other C- C chemokines (monocyte chemoattractant protein-3 and RANTES). J. Immunol. (1999) 163:3976–3984.
   PubMed Web of Science ®Google Scholar
• MACLEAN JA, OWNBEY R, LUSTER AD: T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila. J. Exp. Med. (1996) 184:1461–1469.
   PubMed Web of Science ®Google Scholar
• MATTOLI S, STACEY MA, SUN G, BELLINI A, MARINI M: Eotaxin expression and eosinophilic inflammation in asthma. Biochem. Biophys. Res. Commun. (1997) 236:299–301.
   PubMed Web of Science ®Google Scholar
• HEATH H, QIN S, RAO P et al: Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. (1997) 99:178–184.
   Google Scholar
• GRIMALDI JC, YU NX, GRUNIG G et al.: Depletion of eosinophils in mice through the use of antibodies specific for C-C chemokine receptor 3 (CCR3). J. Leukoc. Biol. (1999) 65:846–853.
   PubMed Web of Science ®Google Scholar
• SABROE I, CONROY DM, GERARD NP et al: Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo. J. Immunol. (1998) 161:6139–6147.
   PubMed Web of Science ®Google Scholar
• GONG JH, UGUCCIONI M, DEWALD B, BAGGIOLINI M,CLARK-LEWIS I: RANTES and MCP-3 antagonists bind multiple chemokine receptors. J. Biol. Chem. (1996) 271:10521–10527.
   PubMed Web of Science ®Google Scholar
• WEBER M, UGUCCIONI M, BAGGIOLINI M, CLARK-LEWIS I, DAHINDEN CA: Deletion of the N112-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J. Exp. Med. (1996) 183:681–685.
   PubMed Web of Science ®Google Scholar
• WELLS TN, POWER CA, LUSTI-NARASIMHAN M et al: Selectivity and antagonism of chemokine receptors. J. Leukoc. Biol. (1996) 59:53–60.
   PubMed Web of Science ®Google Scholar
• PROUDFOOT AE, POWER CA, HOOGEWERF AJ et al: Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J. Biol. Chem. (1996) 271:2599–2603.
   PubMed Web of Science ®Google Scholar
• ELSNER J, PETERING H, HOCHSTETTER R et al.: The CC chemokine antagonist Met-RANTES inhibits eosino-phil effector functions through the chemokine receptors CCR1 and CCR3. Eur. J. Immunol. (1997) 27:2892–2898.
   PubMed Web of Science ®Google Scholar
• KIPS JC, PALMANS E, PROUDFOOT AEI et al: The effect ofMet-RANTES on the allergen induced airway eosino-philia in an in vivo mouse model. Am. J. Respir. Grit. Care Med. (1997) 155:A733.
   Google Scholar